EUVIMEDEUVIMED entdecken
Crossref

Tirzepatide improves neutrophilic inflammation in obese asthmatic mice by downregulating Th17 cell differentiation

Lu Sun, Su-Yan Yao, Zhong-Fu Zuo, Sheng-Xue Yu, Hong-Dan Yu, Qing-Lin Sun, Han-Song Zheng, Yang Hou, Si-Jing Lu, Tie-Feng Yao

Molecular Biology Reports · 2026

DOI: 10.1007/s11033-025-11366-6 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Molecular Biology Reports, 2026. Verfasst von Lu Sun und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathology, Jinzhou Medical University, Jinzhou, China. Hauptthemen laut MEDLINE: Tirzepatide, Th17 Cells, Asthma, Obesity. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 49 Literaturangaben. Gefördert von: Foundation of Education Department of Liaoning Province, Natural Science Foundation of Liaoning Province of China, Horizontal project of Jinzhou Medical University.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Asthma is a chronic respiratory disease affecting more than 330 million people worldwide. Obesity not only increases the risk of asthma attacks but also worsens symptoms and diminishes responsiveness to standard drug treatments. Tirzepatide, a dual GIP and GLP-1 receptor agonist, has demonstrated superior glycemic control and weight loss effects compared to selective GLP-1 receptor agonists in clinical trials. However, its impact on neutrophilic inflammation in obese asthmatic mice and the underlying molecular mechanisms remain unclear. METHODS: This study first established an obese mice model using a high-fat diet, followed by ovalbumin (OVA) sensitization and challenge to induce asthma. Glucose tolerance was assessed via oral glucose tolerance tests (OGTT), while body weight and blood glucose levels were monitored regularly. Pathological changes in lung tissue were evaluated using H&E and Masson’s trichrome staining. Serum leptin and insulin concentrations were measured by ELISA, and gene and protein expression levels were analyzed by qRT-PCR and Western blot, respectively. Additionally, the proportions of Th17 cells and neutrophils were determined by flow cytometry, and neutrophil migration was assessed through Transwell assays. RESULTS: Obesity exacerbates neutrophilic inflammation and asthma pathology in mice. Tirzepatide reduced airway inflammation and neutrophil aggregation in obese asthmatic mice by inhibiting the Notch signaling pathway, which in turn decreased the differentiation of Th17 cells. Both in vivo and in vitro experiments demonstrated that Tirzepatide suppresses the Notch signaling pathway, thereby reducing neutrophil recruitment mediated by Th17 cells. CONCLUSION: This study demonstrates that obesity-induced Th17 differentiation exacerbates neutrophilic inflammation in asthmatic mice. Tirzepatide reduces neutrophilic inflammation in obese asthmatic mice by inhibiting the NOTCH signaling pathway and suppressing Th17 differentiation. These findings offer new insights for the clinical treatment of obesity-related asthma.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

TirzepatideTh17 CellsAsthmaObesityNeutrophilsAnimalsMiceCell DifferentiationInflammationDisease Models, AnimalMice, ObeseSignal TransductionMale

Stichwörter der Autor:innen

Obesity-related asthma · Th17 · Tirzepatide · NOTCH · Neutrophil

Substanzen

Tirzepatide

Autor:innen und Institutionen

  • Department of Pathology, Jinzhou Medical University, Jinzhou, China.
  • Department of pathophysiology, Jinzhou Medical University, Jinzhou, China.
  • Department of Anatomy, Histology and Embryology, Jinzhou Medical University, Jinzhou, China.
  • Liaoning Key Laboratory of Diabetic Cognitive and Perceptive Dysfunction, Jinzhou Medical University, Jinzhou, China.
  • Department of Third Clinical College, Jinzhou Medical University, Jinzhou, China.
  • Department of First Clinical College, Tianjin Medical University, Tianjin, China.

Förderung

  • Foundation of Education Department of Liaoning Province
  • Natural Science Foundation of Liaoning Province of China
  • Horizontal project of Jinzhou Medical University

Zitieren

APA

Sun, L., Yao, S. Y., Zuo, Z. F., Yu, S. X., Yu, H. D., Sun, Q. L., Zheng, H. S., Hou, Y., Lu, S. J., & Yao, T. F. (2026). Tirzepatide improves neutrophilic inflammation in obese asthmatic mice by downregulating Th17 cell differentiation. Molecular Biology Reports. https://doi.org/10.1007/s11033-025-11366-6

Vancouver

Sun L, Yao SY, Zuo ZF, Yu SX, Yu HD, Sun QL, et al. Tirzepatide improves neutrophilic inflammation in obese asthmatic mice by downregulating Th17 cell differentiation. Molecular Biology Reports. 2026. doi:10.1007/s11033-025-11366-6

BibTeX
@article{Sun2026,
  author = {Sun, Lu and Yao, Su-Yan and Zuo, Zhong-Fu and Yu, Sheng-Xue and Yu, Hong-Dan and Sun, Qing-Lin and Zheng, Han-Song and Hou, Yang and Lu, Si-Jing and Yao, Tie-Feng},
  title = {Tirzepatide improves neutrophilic inflammation in obese asthmatic mice by downregulating Th17 cell differentiation},
  journal = {Molecular Biology Reports},
  year = {2026},
  doi = {10.1007/s11033-025-11366-6}
}
Kostenlos starten →